AU2121895A - Low dosage ketoprofen - Google Patents

Low dosage ketoprofen

Info

Publication number
AU2121895A
AU2121895A AU21218/95A AU2121895A AU2121895A AU 2121895 A AU2121895 A AU 2121895A AU 21218/95 A AU21218/95 A AU 21218/95A AU 2121895 A AU2121895 A AU 2121895A AU 2121895 A AU2121895 A AU 2121895A
Authority
AU
Australia
Prior art keywords
ketoprofen
low dosage
pain
dosage
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21218/95A
Other languages
English (en)
Inventor
William G Byrd
Georg Frank
Manfred Hanisch
Albrecht Hoburg
Bernhard Streuff
Daniel E Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of AU2121895A publication Critical patent/AU2121895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU21218/95A 1994-03-18 1995-03-15 Low dosage ketoprofen Abandoned AU2121895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21083294A 1994-03-18 1994-03-18
US210832 1994-03-18
PCT/US1995/003335 WO1995025511A1 (en) 1994-03-18 1995-03-15 Low dosage ketoprofen

Publications (1)

Publication Number Publication Date
AU2121895A true AU2121895A (en) 1995-10-09

Family

ID=22784436

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21218/95A Abandoned AU2121895A (en) 1994-03-18 1995-03-15 Low dosage ketoprofen

Country Status (4)

Country Link
EP (1) EP0785779A1 (enExample)
AU (1) AU2121895A (enExample)
CA (1) CA2185805A1 (enExample)
WO (1) WO1995025511A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL124419A0 (en) * 1995-12-07 1998-12-06 Lilly Co Eli Composition for treating pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1546478A (fr) * 1967-01-27 1968-11-22 Rhone Poulenc Sa Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation
US4868214A (en) * 1987-11-17 1989-09-19 Analgesic Associates Onset-hastened/enhanced analgesia
US4962124A (en) * 1987-11-17 1990-10-09 Analgesic Associates Onset-hastened/enhanced antipyretic response
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen

Also Published As

Publication number Publication date
CA2185805A1 (en) 1995-09-28
EP0785779A1 (en) 1997-07-30
EP0785779A4 (enExample) 1997-07-30
WO1995025511A1 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
DeArmond et al. Safety profile of over-the-counter naproxen sodium
Altman et al. Topical therapy for osteoarthritis: clinical and pharmacologic perspectives
JPS61501913A (ja) 非ステロイド系抗炎症剤を含むせき/かぜ複合薬
Spooner et al. The history and usage of paracetamol
Pfaffenrath et al. Analgesics and NSAIDs in the treatment of the acute migraine attack
KR930007441A (ko) 의약품
JP3018160B2 (ja) 月経困難症及び/又は月経前症候群の軽減用薬剤
Berry et al. Indomethacin and naproxen suppositories in the treatment of rheumatoid arthritis.
Bourgeois et al. Multi-centre double-blind study to define the most favourable dose of nimesulide in terms of efficacy/safety ratio in the treatment of osteoarthritis
Bansal et al. A look at the safety profile of over‐the‐counter naproxen sodium: a meta‐analysis
EP0657167A3 (fr) Application de l'oenothéine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, les compositions pharmaceutiques le contenant et un procédé de préparation à partir d'Epilobium Parviflorum.
Boardman et al. Ibuprofen in the treatment of rheumatoid arthritis and osteo-arthritis
Kashefimehr et al. Effect of prophylactic administration of Novafen for periodontal surgery on postoperative pain relief
US4730007A (en) Novel analgesic compositions
US4260600A (en) Method of treating depression
CA2151912A1 (en) Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
Cooper et al. Ibuprofen controlled-release formulation: A clinical trial in dental impaction pain
Forbes et al. A 12‐hour evaluation of the analgesic efficacy of diflunisal, propoxyphene, a propoxyphene‐acetaminophen combination, and placebo in postoperative oral surgery pain
AU2121895A (en) Low dosage ketoprofen
EP0529898A1 (en) Potentiation of the antitussive effect of dextromethorphan with acetaminophen (paracetamol)
Furniss Nonsteroidal anti-inflammatory agents in the treatment of primary dysmenorrhea
KR890014110A (ko) 의약제
US5998478A (en) Timed release tablet comprising naproxen and pseudoephedrine
AU605538B2 (en) Pharmaceutical unit
Toft et al. A double-blind, crossover study of a sustained-release tablet of ketoprof en and normal ketoprof en capsules in the treatment of patients with osteoarthritis